Cargando…

EGFR alterations in glioblastoma play a role in antitumor immunity regulation

The epidermal growth factor receptor (EGFR) is the most frequently altered gene in glioblastoma (GBM), which plays an important role in tumor development and anti-tumor immune response. While current molecular targeted therapies against the EGFR signaling pathway and its downstream key molecules hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Peng, Guo, Zheng-Qian, Wang, Bao-Feng, Zhao, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436475/ https://www.ncbi.nlm.nih.gov/pubmed/37601668 http://dx.doi.org/10.3389/fonc.2023.1236246

Ejemplares similares

Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation
por: Chen, Zheng, et al.
Publicado: (2020)

S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma
por: Huang, Wenda, et al.
Publicado: (2022)

Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
por: El Khayari, Abdellatif, et al.
Publicado: (2022)

Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy
por: Zhang, Ke, et al.
Publicado: (2023)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling
por: Song, Hai, et al.
Publicado: (2021)

Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression
por: Wang, Min, et al.
Publicado: (2021)

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma
por: Xu, Zhanyu, et al.
Publicado: (2021)

Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
por: Valtorta, Silvia, et al.
Publicado: (2021)

RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
por: Pan, Yimin, et al.
Publicado: (2021)

Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment
por: Sun, Kexiang, et al.
Publicado: (2022)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
por: Wang, Ting, et al.
Publicado: (2023)

The Role of Microglia in Glioblastoma
por: Geribaldi-Doldán, Noelia, et al.
Publicado: (2021)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Characteristics of glioblastomas and immune microenvironment in a Chinese family with Lynch syndrome and concurrent porokeratosis
por: Yao, Zhi-Gang, et al.
Publicado: (2023)

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review
por: Guo, Yijia, et al.
Publicado: (2020)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
por: Cheng, Lanming, et al.
Publicado: (2020)

Immune Checkpoints and Innovative Therapies in Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer
por: Zhao, Jing, et al.
Publicado: (2021)

MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells
por: Zhu, Yan, et al.
Publicado: (2021)

Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis
por: Chen, Xishan, et al.
Publicado: (2021)

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
por: Guo, Zong Sheng, et al.
Publicado: (2014)

5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis
por: Ricciardi, Luca, et al.
Publicado: (2022)

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
por: Luo, YingHao, et al.
Publicado: (2023)

Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
por: Gupta, Kshama, et al.
Publicado: (2018)

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
por: Wiest, Nathaniel, et al.
Publicado: (2021)

Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity
por: Hernandez, Rosmely, et al.
Publicado: (2022)

P. aeruginosa Mediated Necroptosis in Mouse Tumor Cells Induces Long-Lasting Systemic Antitumor Immunity
por: Qi, Jia-long, et al.
Publicado: (2021)

Corrigendum: Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer
por: Zhao, Jing, et al.
Publicado: (2022)

How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?
por: Janelle, Valérie, et al.
Publicado: (2014)

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
por: Cai, Hong-Qing, et al.
Publicado: (2020)

Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy
por: Weng, Qiaoyou, et al.
Publicado: (2021)

Yin and yang roles of B lymphocytes in solid tumors: Balance between antitumor immunity and immune tolerance/immunosuppression in tumor-draining lymph nodes
por: Katakai, Tomoya
Publicado: (2023)

Regulation of antitumor immunity by inflammation-induced epigenetic alterations
por: Karin, Michael, et al.
Publicado: (2021)

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report
por: Wang, Lingfei, et al.
Publicado: (2020)

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
por: Chiang, Ming-Fu, et al.
Publicado: (2013)

The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon EGFR Mutations—The Mutation Patterns, Use of Different Generations of EGFR-TKIs, and Concurrent Genetic Alterations
por: Tan, Jiarong, et al.
Publicado: (2021)

LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway
por: Gao, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jfsbh30rnsa8q4u3419nr20ok0